<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://hdl.handle.net/123456789/1583">
<title>ISOLATION OF BIOACTIVE COMPOUNDS FROM SELECTED NIGERIAN  MEDICINAL PLANTS FOR MANAGEMENT OF LETROZOLE-INDUCED  POLYCYSTIC OVARIAN SYNDROME IN RATS</title>
<link>http://hdl.handle.net/123456789/1583</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://hdl.handle.net/123456789/1584"/>
</rdf:Seq>
</items>
<dc:date>2026-04-19T07:27:28Z</dc:date>
</channel>
<item rdf:about="http://hdl.handle.net/123456789/1584">
<title>ISOLATION OF BIOACTIVE COMPOUNDS FROM SELECTED NIGERIAN  MEDICINAL PLANTS FOR MANAGEMENT OF LETROZOLE-INDUCED  POLYCYSTIC OVARIAN SYNDROME IN RATS</title>
<link>http://hdl.handle.net/123456789/1584</link>
<description>ISOLATION OF BIOACTIVE COMPOUNDS FROM SELECTED NIGERIAN  MEDICINAL PLANTS FOR MANAGEMENT OF LETROZOLE-INDUCED  POLYCYSTIC OVARIAN SYNDROME IN RATS
OGUNLAKIN, AKINGBOLABO DANIEL
Polycystic Ovary Syndrome (PCOS) is an endocrine disorder with a global prevalence of 5-10% &#13;
among women of reproductive age. Women with PCOS have a 2.7-fold increased risk of developing &#13;
ovarian and cervical cancers. Ethnobotanical survey revealed that plants including Kigelia africana &#13;
(Lam.) Benth. (KA), Basella alba L. (BA), Tetracera potatoria G. Don (TP) and Mormodica &#13;
charantia L. (MC) are used for treatment of PCOS in southwestern Nigeria. However, there is no &#13;
reported scientific evidence to validate these claims. This study was, therefore, designed to &#13;
investigate the effect of the four plants in alleviating polycystic ovary conditions in rats and the &#13;
associated risk of ovarian and cervical cancers.&#13;
Letrozole (1 mg/kg) was used for the induction of PCOS in thirty female albino rats (180-200 g, &#13;
n=5). Methanol leaf extracts of KA, BA, TP and MC (100 mg/kg b.w.) and Clomiphene citrate (1 &#13;
mg/kg b.w., standard drug) were administered for 15 days. Histopathological evaluation of the &#13;
ovaries was done microscopically. Luteinizing hormone (LH), follicle stimulating hormone (FSH) &#13;
and estradiol were measured using ELISA. Extracts of the most active plants, KA (FHI-111350) and &#13;
TP (IFE-17794) were successively partitioned into n-hexane, dichloromethane and ethyl acetate &#13;
fractions, and screened for PCOS inhibitory activity. Compounds were isolated from the active &#13;
fractions using chromatographic techniques. Structures of isolated compounds were elucidated using &#13;
spectroscopic techniques. Anti-proliferative effect of fractions, isolated compounds and derivatised &#13;
cinnamic acid analogues were determined on cervix adenocarcinoma (HeLa) and Chinese Hamster &#13;
ovarian (CHO 1) cell lines using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide &#13;
(MTT) assay. Doxorubicin was used as standard. Data were analysed using one-way ANOVA &#13;
followed by Student’s t-test at α0.05.&#13;
Animals treated with KA showed normal ovarian stroma with moderate fibroblastic tissues. The &#13;
levels of FSH in KA, BA, TP and MC treated groups were 0.96±0.08, 1.10±0.23, 0.81±0.04 and &#13;
0.69±0.01 mIU/mL, respectively compared to control group (0.93±0.19 mIU/mL). The TP &#13;
(0.19±0.05 mIU/mL) significantly reduced the level of LH compared with the control group &#13;
(0.22±0.0l mIU/mL). Hexane and ethyl acetate fractions displayed selective moderate inhibitory &#13;
effect (IC50 = 5.3±1.10 µg/mL) on CHO 1 cell line compared to doxorubicin (IC50 = 0.8±0.01 µg/mL). &#13;
Compounds 3-(3, 4-dimethoxyphenyl) acrylic acid (1), sitosterol (2), methyl 3-(3,4-&#13;
dihydroxyphenyl) acrylate (3), 2, 3-dihydro-5-(hydroxymethyl) furan-2, 3, 4-triol (4), p-coumaric &#13;
acid (5) and caffeic acid (6) were isolated from KA, while apigenin (7) was isolated from TP.&#13;
iii&#13;
Compound 1 displayed moderate anti-proliferative activity against HeLa cell line (IC50 = 33.5±0.60&#13;
µg/mL). Compound 7 inhibited proliferation of HeLa cell line (IC50 = 6.2 µg/mL) and had moderate &#13;
inhibitory effect on CHO l cell line (IC50 = 22.2 µg/mL). Derivatised compound N'-(2, 6-&#13;
dimethoxybenzylidene)-3-(4-methoxyphenyl) acrylohydrazide (8) inhibited both CHO l (IC50 = &#13;
l8.4±4.l µg/mL) and HeLa (IC50 = 22.4±0.4 µg/mL) cells.&#13;
The extracts of Kigelia africana and Tetracera potatoria had inhibitory effects on polycystic ovary &#13;
condition, irregular oestrual cycle and hormonal imbalance in female albino rats. The &#13;
phenylpropanoids and derivatised analogues exhibited antiproliferative effect on ovarian and cervical &#13;
cancer cell lines, which could contribute to their use for management of polycystic ovary syndrome.
</description>
<dc:date>2021-02-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
